Cellular and Molecular Biotechnology Research Institute, National Institute of Advanced Industrial Science and Technology, Higashi, Tsukuba, Ibaraki, Japan.
PLoS Comput Biol. 2024 Sep 30;20(9):e1012480. doi: 10.1371/journal.pcbi.1012480. eCollection 2024 Sep.
Recent advances in measurement technologies, particularly single-cell RNA sequencing (scRNA-seq), have revolutionized our ability to acquire large amounts of omics-level data on cellular states. As measurement techniques evolve, there has been an increasing need for data analysis methodologies, especially those focused on cell-type identification and inference of gene regulatory networks (GRNs). We have developed a new method named BootCellNet, which employs smoothing and resampling to infer GRNs. Using the inferred GRNs, BootCellNet further infers the minimum dominating set (MDS), a set of genes that determines the dynamics of the entire network. We have demonstrated that BootCellNet robustly infers GRNs and their MDSs from scRNA-seq data and facilitates unsupervised identification of cell clusters using scRNA-seq datasets of peripheral blood mononuclear cells and hematopoiesis. It has also identified COVID-19 patient-specific cells and their potential regulatory transcription factors. BootCellNet not only identifies cell types in an unsupervised and explainable way but also provides insights into the characteristics of identified cell types through the inference of GRNs and MDS.
近年来,测量技术,尤其是单细胞 RNA 测序(scRNA-seq)的进步,极大地提高了我们获取细胞状态的组学水平数据的能力。随着测量技术的发展,数据分析方法的需求也在不断增加,特别是那些专注于细胞类型识别和基因调控网络(GRN)推断的方法。我们开发了一种名为 BootCellNet 的新方法,该方法使用平滑和重采样来推断 GRN。利用推断出的 GRN,BootCellNet 进一步推断出最小支配集(MDS),即一组决定整个网络动态的基因。我们已经证明,BootCellNet 可以从 scRNA-seq 数据中稳健地推断出 GRN 及其 MDS,并使用外周血单核细胞和造血的 scRNA-seq 数据集来促进细胞群的无监督识别。它还鉴定了 COVID-19 患者特异性细胞及其潜在的调节转录因子。BootCellNet 不仅可以以无监督和可解释的方式识别细胞类型,还可以通过推断 GRN 和 MDS 来提供对鉴定出的细胞类型特征的深入了解。